Elizabeth McMahon, PhD
Elizabeth McMahon, PhD, is an expert on Virtual Reality Therapy (VRT) for anxiety and an engaging and sought-after teacher known for her ability to translate research into practical skills for clinicians. She has been using VR in therapy and training other therapists in this technology since 2010.
Dr. McMahon has presented at VR and healthcare conferences, at the Technology Mind & Society conference, and has taught accredited CE workshops for PESI, APA, California Psychological Association, regional psychological associations, and other organizations. Her 10-week webinar on VRT was attended by therapists around the world and her talks receive ratings.
Her workbook, Overcoming Anxiety and Panic Interactive Guide helps clients prepare for treatment. Her therapist workbook, Virtual Reality Therapy for Anxiety: A Guide for Therapists, will be published in 2021 in Routledge.
Dr. McMahon earned her PhD in clinical psychology from Case Western Reserve University, completed a post-doctoral residency at Sheppard-Pratt Psychiatric Hospital, and worked for Kaiser Psychiatry Department in Fremont before entering private practice. While at Kaiser, she helped create regional best practices for anxiety disorders, wrote the first health education class on anxiety, supervised post-doctoral psychology residents, and gave numerous presentations on anxiety and using VR to professional and lay audiences.
Financial: Dr. Elizabeth McMahon maintains a private practice and receives compensation as a consultant. She is a published author and receives royalties. Dr. McMahon receives a speaking honorarium and recording royalties from PESI, Inc. She has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Elizabeth McMahon is a member of the American Psychological Association, the Anxiety and Depression Association of America, and the Association for Behavioral and Cognitive Therapies. She is a blogger for PsychologyToday.com. Dr. McMahon serves on the advisory board for MindCo Health and Limbix.